Malaria - World Health Organization (WHO)
Dec 4, 2023 · There are 5 Plasmodium parasite species that cause malaria in humans and 2 of these species – P. falciparum and P. vivax – pose the greatest threat. P. falciparum is the deadliest malaria parasite and the most prevalent on the African continent. P. vivax is the dominant malaria parasite in most countries outside of sub-Saharan Africa.
Malaria - World Health Organization (WHO)
Dec 4, 2023 · Malaria eradication refers to the complete interruption of malaria transmission globally, in all countries. Malaria is an acute febrile illness caused by Plasmodium parasites, which are spread to people through the bites of infected female Anopheles mosquitoes. It …
Malaria - World Health Organization (WHO)
Oct 20, 2024 · Malaria. Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. It is preventable and curable. There are 5 parasite species that cause malaria in humans, and 2 of these species – Plasmodium falciparum and Plasmodium vivax – pose the greatest threat.
Malaria - World Health Organization (WHO)
Jun 9, 2013 · Malaria is a parasitic disease caused by protozoa of the genus Plasmodium. Humans become infected with malaria through the bite of a female mosquito belonging to the genus Anopheles. Four Plasmodium spp. cause malaria in human beings, including P. falciparum, P. vivax, P. ovale and P. malariae. Cases caused by the most common of these species ...
Diagnostic tests for detecting risk of Plasmodium vivax relapse
Apr 8, 2024 · Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic anaemia and increased morbidity and mortality.
Control and elimination of Plasmodium vivax malaria – A technical …
Aug 27, 2015 · The technical brief also describes the innovations required to facilitate P. vivax elimination and highlights the need for international donors and governments to invest in additional measures to control, eliminate and prevent re-establishment of P. vivax. Confronting Plasmodium vivax malaria is the advocacy companion of the technical brief.
ersion – eectie date 00206 giemsa staining of malaria blood films malaria microscopy standard operating procedure – mm-sop-07a
Global Malaria Programme - World Health Organization (WHO)
Global Malaria Programme. The WHO Global Malaria Programme (GMP) is responsible for coordinating WHO's global efforts to control and eliminate malaria. Its work is guided by the "Global technical strategy for malaria 2016–2030" adopted by the World Health Assembly in May 2015 and updated in 2021. About us.
New opportunities to prevent Plasmodium vivax malaria relapse
Feb 25, 2019 · A new medicine, tafenoquine, offers fresh hope in global efforts to combat P. vivax malaria. Tafenoquine has the distinct advantage of being a single-dose treatment, thereby increasing the likelihood of treatment compliance. It was recently approved by 2 stringent regulatory agencies, the United States Food and Drug Administration and the ...
WHO Guidelines for malaria
Oct 16, 2023 · This version of the Guidelines includes revised information regarding the WHO recommendation for use of indoor residual spraying to prevent malaria and the conditional recommendation against the use of topical repellents to control malaria at the community level. It replaces the versions published on 16 February 2021, 13 July 2021, 18 February ...